fda-approves-interchangeable-biosimilar-for-multiple-inflammatory-diseases 2023-11-01T17:00:42.036Z 3665f6cd-25c6-4c1b-9a81-3f61a93a68e4 324813be-a93e-485a-89bd-8464e4a412e0 mas_evidence_types:Media%20and%20commentaries Media and commentaries FDA have approved biosimilar ustekinumab-auub (Wezlana by Amgen) in the USA. It is approved for the same indications, and considered interchangeable with Stelara (ustekinumab) for use in adults and children aged 6 years and over. <p>Wezlana is not (yet) available in the UK. Several ustekinumab biosimilar products are in development globally.</p> https://www.medicinesresources.nhs.uk/fda-approves-interchangeable-biosimilar-for-multiple-inflammatory-diseases.html https://www.fda.gov/news-events/press-announcements/fda-approves-interchangeable-biosimilar-multiple-inflammatory-diseases 2023-10-31T00:00:00Z 2023-11-01T16:21:02.933Z